Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Schneider, Katja U ^a   Dietrich, Dimo ^b   Fleischhacker, Michael ^c   Leschber, Gunda ^d   Merk, Johannes ^d   Schäper, Frank ^d   Stapert, Henk R ^e   Vossenaar, Erik R ^e   Weickmann, Sabine ^c   Liebenberg, Volker ^f   Kneip, Christoph ^g   Seegebarth, Anke ^h   Erdogan, Fikret ⁱ   Rappold, Gudrun ^a   Schmidt, Bernd ^j  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b EPIGENOMICS AG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d ELK Berlin Chest Hospital   (Germany)

^e Biocartis SA   (Belgium)

^f Metanomics GmbH   (Germany)

^g Theracode GmbH   (Germany)

^h Bavarian Nordic GmbH   (Germany)

ⁱ ATLAS BIOLABS GMBH   (Germany)

^j MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; HOMEODOMAIN PROTEIN; SHOX2 PROTEIN, HUMAN;

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DNA METHYLATION; GENE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENE LOCUS; GERMANY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG LAVAGE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; SHOX2 GENE; CARCINOMA; GENETIC POLYMORPHISM; GENETICS; LUNG TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS;

CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; GENE AMPLIFICATION; GENE DOSAGE; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MATCHED-PAIR ANALYSIS; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 79953072405     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-102     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. Roth K, Hardie JA, Andreassen AH, Leh F, Eagan TM. Predictors of diagnostic yield in bronchoscopy: a retrospective cohort study comparing different combinations of sampling techniques. BMC Pulm Med 2008, 8:2. 10.1186/1471-2466-8-2, 2267157, 18221551.
3. Greenberg AK, Lee MS. Biomarkers for lung cancer: clinical uses. Curr Opin Pulm Med 2007, 13:249-55. 10.1097/MCP.0b013e32819f8f06, 17534168.
4. Chorostowska-Wynimko J, Szpechcinski A. The impact of genetic markers on the diagnosis of lung cancer: a current perspective. J Thorac Oncol 2007, 2:1044-1051. 10.1097/JTO.0b013e318158eed4, 17975498.
5. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer--a survey. Biochim Biophys Acta 2007, 1775:181-232.
6. Schmiemann V, Böcking A, Kazimirek M, Onofre AS, Gabbert HE, Kappes R, Gerharz CD, Grote HJ. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study. Clin Cancer Res 2005, 11:7728-7734. 10.1158/1078-0432.CCR-05-0999, 16278393.
7. Anglim PP, Alonzo TA, Laird-Offringa IA. DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update. Mol Cancer 2008, 7:81. 10.1186/1476-4598-7-81, 2585582, 18947422.
8. Anglim PP, Galler JS, Koss MN, Hagen JA, Turla S, Campan M, Weisenberger DJ, Laird PW, Siegmund KD, Laird-Offringa IA. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer. Mol Cancer 2008, 7:62. 10.1186/1476-4598-7-62, 2483990, 18616821.
9. Ehrich M, Field JK, Liloglou T, Xinarianos G, Oeth P, Nelson MR, Cantor CR, van den Boom D. Cytosine methylation profiles as a molecular marker in non-small cell lung cancer. Cancer Res 2006, 66:10911-10918. 10.1158/0008-5472.CAN-06-0400, 17108128.
10. Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, Kotsinas A, Gorgoulis V, Field JK, Liloglou T. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 2009, 124:81-87. 10.1002/ijc.23849, 18823011.
11. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610. 10.1038/nrg1655, 16136652.
12. Ting AH, McGarvey KM, Baylin SB. The cancer epigenome--components and functional correlates. Genes Dev 2006, 20:3215-3231. 10.1101/gad.1464906, 17158741.
13. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003, 3:253-266. 10.1038/nrc1045, 12671664.
14. Schmidt B, Liebenberg V, Dietrich D, Schlegel T, Kneip C, Seegebarth A, Seemann S, Distler J, Tetzner R, Weickmann S, Wille U, Liloglou T, Walshaw M, Fleischhacker M, Witt C, Field JK. SHOX2 DNA Methylation is a Biomarker for the Diagnosis of Lung Cancer Based on Bronchial Aspirates. BMC Cancer 2010, 10:600. 10.1186/1471-2407-10-600, 2988753, 21047392.
15. Blaschke RJ, Monaghan AP, Schiller S, Schechinger B, Rao E, Padilla-Nash H, Ried T, Rappold GA. SHOT, a SHOX-related homeobox gene, is implicated in craniofacial, brain, heart, and limb development. Proc Natl Acad Sci USA 1998, 95:2406-2411. 10.1073/pnas.95.5.2406, 19357, 9482898.
16. Blaschke RJ, Hahurij ND, Kuijper S, Just S, Wisse LJ, Deissler K, Maxelon T, Anastassiadis K, Spitzer J, Hardt SE, Schöler H, Feitsma H, Rottbauer W, Blum M, Meijlink F, Rappold G, Gittenberger-de Groot AC. Targeted mutation reveals essential functions of the homeodomain transcription factor Shox2 in sinoatrial and pacemaking development. Circulation 2007, 115:1830-1838. 10.1161/CIRCULATIONAHA.106.637819, 17372176.
17. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S, Rappold GA. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 2000, 9:695-702. 10.1093/hmg/9.5.695, 10749976.
18. Marchini A, Rappold G, Schneider KU. SHOX at a glance: from gene to protein. Arch Physiol Biochem 2007, 113:116-123. 10.1080/13813450701531201, 17922307.
19. Qian J, Massion PP. Role of chromosome 3q amplification in lung cancer. J Thorac Oncol 2008, 3:212-5. 10.1097/JTO.0b013e3181663544, 18317062.
20. Shen H, Gao W, Wu YJ, Qiu HR, Shu YQ. Multicolor fluorescence in situ hybridization and comparative genomic hybridization reveal molecular events in lung adenocarcinomas and squamous cell lung carcinomas. Biomed Pharmacother 2009, 63:396-403. 10.1016/j.biopha.2008.08.010, 18848758.
21. Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, Rienstein S, Simansky D, Krupsky M, Yaron P, Friedman E, Rechavi G, Perlman M, Aviram-Goldring A, Izraeli S, Bittner M, Yakhini Z, Kaminski N. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 2007, 56:175-84. 10.1016/j.lungcan.2006.12.010, 17258348.
22. Yen CC, Liang SC, Jong YJ, Chen YJ, Lin CH, Chen YM, Wu YC, Su WC, Huang CY, Tseng SW, Whang-Peng J. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits. Lung Cancer 2007, 57:292-301. 10.1016/j.lungcan.2007.04.007, 17553591.
23. Huang YT, Heist RS, Chirieac LR, Lin X, Skaug V, Zienolddiny S, Haugen A, Wu MC, Wang Z, Su L, Asomaning K, Christiani DC. Genome-wide analysis of survival in early-stage non-small-cell lung cancer. J Clin Oncol 2009, 27:2660-7. 10.1200/JCO.2008.18.7906, 2690391, 19414679.
24. Kneip C, Schmidt B, Fleischhacker M, Seegebarth A, Lewin J, Flemming N, Seemann S, Schlegel T, Witt C, Liebenberg V, Dietrich D. A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling. Biotechniques 2009, 47:737-44. 10.2144/000113208, 19852759.
25. Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Gräf S, Johnson N, Herrero J, Tomazou EM, Thorne NP, Bäckdahl L, Herberth M, Howe KL, Jackson DK, Miretti MM, Marioni JC, Birney E, Hubbard TJ, Durbin R, Tavaré S, Beck S. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol 2008, 26:779-85. 10.1038/nbt1414, 2644410, 18612301.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-8. 10.1006/meth.2001.1262, 11846609.
27. Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999, 270:41-9. 10.1006/abio.1999.4085, 10328763.
28. Cottrell SE, Distler J, Goodman NS, Mooney SH, Kluth A, Olek A, Schwope I, Tetzner R, Ziebarth H, Berlin K. A real-time PCR assay for DNA-methylation using methylation-specific blockers. Nucleic Acids Res 2004, 32:e10. 10.1093/nar/gnh008, 373310, 14722226.
29. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349:2042-2054. 10.1056/NEJMra023075, 14627790.
30. Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 1997, 25:4422-4426. 10.1093/nar/25.21.4422, 147052, 9336479.
31. Wojdacz TK, Borgbo T, Hansen LL. Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics 2009, 4:231-234.
32. Shen L, Guo Y, Chen X, Ahmed S, Issa JP. Optimizing annealing temperature overcomes bias in bisulfite PCR methylation analysis. Biotechniques 2007, 42:48-52. 10.2144/000112312, 17269485.
33. Yan PS, Venkataramu C, Ibrahim A, Liu JC, Shen RZ, Diaz NM, Centeno B, Weber F, Leu YW, Shapiro CL, Eng C, Yeatman TJ, Huang TH. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 2006, 12:6626-6636. 10.1158/1078-0432.CCR-06-0467, 17121881.
34. Dietrich D, Lesche R, Tetzner R, Krispin M, Dietrich J, Haedicke W, Schuster M, Kristiansen G. Analysis of DNA Methylation of Multiple Genes in Microdissected Cells From Formalin-fixed and Paraffin-embedded Tissues. J Histochem Cytochem 2009, 57:477-489. 10.1369/jhc.2009.953026, 2674771, 19153192.
35. Witz IP. Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 2008, 100:203-229. full_text, 18620097.
36. Li H, Fan X, Houghton J. Tumor microenvironment: the role of the tumor stroma in cancer. J Cell Biochem 2007, 101:805-815. 10.1002/jcb.21159, 17226777.
37. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-318. 10.1080/00313020701329914, 17558857.
38. Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, Moch H, Kristiansen G. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 2008, 14:7430-7437. 10.1158/1078-0432.CCR-08-0935, 19010860.
39. Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol 2006, 310:251-274. full_text, 16909914.